Delivery Order SPE2DE24D0013-SPE2D625F4BFG
- Not listed
- The Defense Department's Medical Supply Chain awarded a $57.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 8, 2025, for molecular diagnostic solutions with an ultimate completion date of September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, will be performed in Sunnyvale, California, where Cepheid manufactures its GeneXpert diagnostic systems and associated test kits. This award carries no set-aside designation and represents a continuation of...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The award, issued on July 30, 2025, with an ultimate completion date of August 6, 2025, carries no set-aside designation and covers diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. Performance will take place at...
- The U.S. Defense Health Agency, through the Medical Supply Chain, awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 12, 2025, for molecular diagnostic solutions with an ultimate completion date of August 19, 2025. This delivery order, designated 4569068770 and titled XPCOV2/FLU/RSV-10, leverages Cepheid's expertise in infectious disease diagnostics and carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale,...
- The Defense Department's Medical Supply Chain has awarded a $24,088.95 delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on July 14, 2025, with an ultimate completion date of July 21, 2025, represents procurement under Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs. The delivery order designation...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,815.72 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on June 27, 2025, for completion by July 7, 2025. The delivery order, identified as XPRSMVP-10, will be performed in Sunnyvale, California, and carries no set-aside designation. Cepheid, a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, specializes in advanced diagnostic systems and test kits for infectious diseases, genetic...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, pertains to XPCOV2/FLU/RSV-10 testing capabilities and carries no set-aside designation. The contract represents work performed under Cepheid's larger indefinite delivery vehicles,...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $7,700 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based molecular diagnostics manufacturer, on September 3, 2025, with an ultimate completion date of September 10, 2025. This delivery order, designated as XPRSARS-COV2-10, carries no set-aside designation and represents procurement of diagnostic solutions from Cepheid's established portfolio of molecular testing systems. The...
- The U.S. Defense Medical Supply Chain awarded a firm fixed-price delivery order valued at $10,200 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 15, 2025, with completion scheduled for August 22, 2025. The delivery order, designated 4569128836 for XPCOV2/FLU/RSV-10 diagnostic solutions, carries no set-aside designation and will be performed at Cepheid's Sunnyvale, California facility. This award represents procurement of molecular diagnostic testing capabilities, specifically for detection of...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $3,638 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on May 30, 2025, with an ultimate completion date of June 13, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside designation and is for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus detection. The work will be performed at Cepheid's facility in...
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a delivery order valued at $1,277.84 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on July 21, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The delivery order represents a continuation of Cepheid's established relationship with federal defense and healthcare agencies as...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F4BFGDelivery Order
The U.S. Defense-affiliated Medical Supply Chain awarded a $8,160 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 23, 2025, with completion scheduled for September 30, 2025. This delivery order, designated XPRS4PLEX-10, was issued without a set-aside designation and represents procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. Cepheid specializes in advanced diagnostic systems and test kits, with particular expertise in detecting infectious diseases including COVID-19, influenza, respiratory syncytial virus (RSV), and other clinical pathogens through its GeneXpert diagnostic platform. This delivery order likely supports the Defense-affiliated Medical Supply Chain's ongoing diagnostic testing requirements and draws from Cepheid's established relationship as a primary supplier of molecular diagnostic equipment and reagents to federal healthcare systems. The company maintains multiple significant indefinite delivery vehicle (IDV) contracts with the Department of Veterans Affairs, including a $32.8 million single-award contract with VA's Veterans Integrated Service Network 6 for diagnostic reagents and assays extending through September 2030, positioning Cepheid as a critical vendor for federal molecular diagnostics procurement. The modest delivery order value indicates a routine replenishment of diagnostic supplies or equipment maintenance services aligned with the Defense health system's operational needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 9/23/25 |